Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
Conditions
Interventions
Intervention1: Group B: Intravenous infusion of propofol will be administered for ERCP procedure titrated to BIS value 60-80.
Intervention2: Group C: In group C, patients will receive i.v. 75 mg of in
Sponsors
DEPARTMENT OF ANAESTHESIA INSTITUTE OF LIVER AND BILIARY SCIENCE
Eligibility
Inclusion criteria
Inclusion criteria: ASA I & ASA II patients between age group 18 to 65 yrs scheduled for ERCP procedure will be recruited for the study.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: Patients will be excluded if they have 1) Age 65 yrs 2) ASA III & IV patients 3) Chronic Liver Disease 4) Pregnant patients 5) Patients with a history of (H/O) Drug abuse 6) Patients refusing consent 7) H/o Acute kidney injury 8) H/o allergy to propofol / lidocaine/ NSAIDS 9) Post liver transplant patients 10) Patients with h/o egg allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BIS monitoring along with pre procedure administration of topical pharyngeal anaesthesia & i.v. diclofenac sodium may be useful adjuvant technique in reducing the dose of propofol thereby reducing side effects and leading to early recovery during ERCP.Timepoint: Untill discharge from day care recovery room | — |
Secondary
| Measure | Time frame |
|---|---|
| BIS monitoring along with pre procedure administration of topical pharyngeal anaesthesia & i.v. diclofenac sodium may be useful adjuvant technique in reducing the dose of propofol thereby reducing side effects and leading to early recovery during ERCP.Timepoint: Untill discharge from day care recovery room | — |
Countries
India
Contacts
Public ContactNIMJE GANESH RAMAJI
INSTITUTE OF LIVER AND BILIARY SCIENCE
Outcome results
None listed